Hematologic Problems of Dialysis Patients

作者: Joseph W. Eschbach

DOI: 10.1007/978-94-009-1087-4_40

关键词: Urinary systemIn vivoErythropoiesisIron deficiencyErythropoietinHemodialysisPeritoneal dialysisPharmacologyAnemiaMedicine

摘要: Recently, there have been numerous significant advances in our knowledge about the pathophysiology and management of anemia chronic renal failure. Aluminum, which dialysis patients receive as phosphate binders, can interfere with erythropoiesis (1, 2); evidence has presented to suggest that uremic inhibitors play a minor, if any, role causation (3, 4); an uremic, anemic sheep model corrected infusions plasma-rich erythropoietin (Epo) no vivo nor vitro erythroid marrow inhibition could be demonstrated (5, 6); finally, recombinant human (rHuEpo) reproduced by genetic technology methods shown clinical trials effective eliminating almost all hemodialysis it given (7, 8). The measurement Epo plasma is now easier more reliable use radioimmunoassays either urinary or Epo.

参考文章(275)
HW Radtke, A Claussner, PM Erbes, EH Scheuermann, W Schoeppe, KM Koch, Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. ,vol. 54, pp. 877- 884 ,(1979) , 10.1182/BLOOD.V54.4.877.877
LEONARD H. BRUBAKER, KARL D. NOLPH, Mechanisms of Recovery From Neutropenia Induced by Hemodialysis Blood. ,vol. 38, pp. 623- 631 ,(1971) , 10.1182/BLOOD.V38.5.623.623
Hemmeloff Andersen Ke, Folic acid status of patients with chronic renal failure maintained by dialysis. Clinical Nephrology. ,vol. 8, pp. 510- 513 ,(1977)
MICHAEL TOREN, JOHN A. GOFFINET, LEONARD S. KAPLOW, Pulmonary Bed Sequestration of Neutrophils During Hemodialysis Blood. ,vol. 36, pp. 337- 340 ,(1970) , 10.1182/BLOOD.V36.3.337.337
J.J.L. Lertora, P.A. Dargon, J.W. Fisher, A.B. Rege, Studies on a radioimmunoassay for human erythopoietin. Journal of Laboratory and Clinical Medicine. ,vol. 86, pp. 140- 151 ,(1975)
Fisher Jw, Extrarenal erythropoietin production. Journal of Laboratory and Clinical Medicine. ,vol. 93, pp. 695- 699 ,(1979)
Pagel M, Ahmad S, Goodman W, Shen F, Accelerated creatinine metabolism and elevated CPK with androgen therapy. Proceedings of the Clinical Dialysis and Transplant Forum. ,vol. 10, pp. 174- ,(1980)
Maher Jf, Hirszel P, Tempel Ge, Mengel Ce, Effect of hemodialysis on factors influencing oxygen transport. Journal of Laboratory and Clinical Medicine. ,vol. 85, pp. 978- ,(1975)
Cattell Wr, Brozovic B, Ackrill P, Nimmon C, Barnett, McAlister J, Baker Lr, Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine. Clinical Nephrology. ,vol. 6, pp. 326- ,(1976)
Feest Tg, Walker W, Sussman M, Aljama P, Bird Pa, Tanboga H, Kerr Dn, Ward Mk, Haemodialysis-induced leucopenia and activation of complement: effects of different membranes. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association. ,vol. 15, pp. 144- ,(1978)